Japan-sourced product information
for clinical evaluation worldwide.

For physicians, clinics and medical distributors seeking Japanese medical products, AIC supports product information, documentation review and international supply discussions for Pure Stem-related products.

Structured information
before implementation.

Cross-border product evaluation requires more than a product name. We begin by clarifying intended use, destination, documentation needs, supply considerations and local requirements so that your organization can assess the next step appropriately.

Product-selection approach

Pure Stem organizes product information and technical documentation with attention to cytokines and growth factors. By reviewing origin, product profile, handling, storage and supply conditions against your intended evaluation context, a medical organization can more readily narrow the product information it needs. The availability and scope of composition or analysis information, as well as product availability, are confirmed individually by product, lot and destination.

Japanese products.
International clinical perspective.

AIC has supported international product discussions across the Philippines and other markets, and is familiar with the practical coordination required for export processing. We help international buyers structure the questions that matter: destination, shipping conditions, available product documentation, labeling considerations and the next professional review.

  • International inquiry coordination across the Philippines and other markets
  • Export-processing and cross-border supply discussions
  • Destination-focused documentation and handling review
  • Clear communication for physicians, clinics and medical distributors
Import clearance, product registration, advertising, distribution and clinical use are subject to the laws and requirements of the destination country. These are confirmed independently for every case.

Products for initial evaluation

We organize manufacturer-supplied information on source, product profile, quality-related documentation and handling conditions. This page is general professional information; specifications and availability are confirmed individually.

01

Research & professional product information

Stem Cell Conditioned Medium FD Rich

A freeze-dried product line with adipose-, dental pulp- and umbilical cord-derived options. Manufacturer materials describe a process for reviewing cytokine- and exosome-related quality information for each production unit.

  • Source-specific product selection
  • Freeze-dried (FD) format
  • Quality-related information for professional review
Intended use and availability must be confirmed against product documentation and local requirements.
02

Research & professional product information

Umbilical Cord Blood-Derived Exosome

A freeze-dried, umbilical cord blood-derived product. Product profile, storage and supply conditions can be reviewed together with quality-related documentation made available by the manufacturer.

  • Umbilical cord blood-derived
  • 0.5 mL per vial product specification
  • Quality-related documentation and supply review
Introduction and intended use require the judgment of qualified professionals.
03

Professional product information

Pure Stem NMN300mg

A freeze-dried NMN product with a 300 mg product specification. We organize composition, product profile, storage and operational considerations to support an evaluation aligned with your intended context.

  • 300 mg NMN product specification
  • Freeze-dried (FD) format
  • Storage and supply conditions reviewed individually
No efficacy or safety outcome is guaranteed.
04

Japan-made supplement information

Pure Stem NMN15000

A Japan-made supplement containing 15,000 mg of β-NMN per bottle in a 90-capsule format. For overseas distribution, labeling and import requirements are reviewed for the destination market.

  • 15,000 mg β-NMN per bottle
  • 90 capsules
  • Japan-made product for export discussions
This is a supplement. Import, labeling and distribution requirements vary by market.
05

Cosmetic product

Exosome Skin Repair Cream 40

A 30 g Japan-made skincare product formulated with ingredients associated with umbilical cord blood, dental pulp and adipose sources. Manufacturer material introduces a liposome-based formulation approach.

  • 30 g / made in Japan
  • Multi-source ingredient formulation
  • International labeling and distribution review
This is a cosmetic product and is not presented as a medicinal product.
06

Professional product information

Pure Stem Nasal Kit

A kit containing freeze-dried material, a dissolving solution, container and handling instructions. Information can be organized around five source options, including conditioned medium, umbilical cord blood-derived exosome and NMN.

  • FD material, solution and container kit
  • Five material-selection options
  • Post-reconstitution handling conditions reviewed
Handling and storage must follow product documentation and professional direction.
07

Medical-collaboration product information

High-Dose Vitamin C (12.5 g / 25 g)

Freeze-dried products in 12.5 g and 25 g formats. Information is organized for medical collaboration where a physician’s assessment and clinical suitability review are prerequisites.

  • 12.5 g / 25 g product formats
  • Freeze-dried (FD) format
  • Physician assessment and suitability review required
No individual treatment effect or safety outcome is guaranteed.
A clinic product-information evaluation setting
Source, product profile and supply conditions are organized around your evaluation context.
Reviewing quality-related documentation
Quality-related documentation and handling conditions are reviewed together.

Documentation for a
more informed evaluation.

Drawing on the structure of manufacturer materials, we organize the practical information a clinic or medical organization needs before the next discussion. The available documentation is confirmed for your product, destination and intended use.

01

Product profile

Review the product name, source, volume, handling, storage and intended-use context.

02

Quality information

Clarify the available specification, composition or analysis, manufacturing and control documentation.

03

Implementation conditions

Discuss destination, availability, required procedures and relevant operational considerations.

Documentation availability, scope and disclosure are confirmed case by case and may vary by product, lot, intended use, destination and the policy of the manufacturer or relevant parties.

A practical review process

  1. 01

    Initial inquiry

    Tell us about your organization, specialty, intended use and destination.

  2. 02

    Information review

    We clarify the product information and documentation needed for your evaluation.

  3. 03

    Supply discussion

    Destination, availability and relevant requirements are reviewed case by case.

  4. 04

    Next-step guidance

    Where appropriate, we guide you through the next required discussion or process.

Japan-sourced information,
reviewed for your destination.

Japan-to-world medical information and supply consultation
We begin with the information and destination-specific questions your organization needs to review.

Professional information only

This page is for general information for medical professionals and organizations. Some listed products may include research materials for medical institutions and may not be intended for diagnosis, treatment or prevention. Product handling, import, distribution, advertising and use requirements vary by product, intended use and jurisdiction. Please complete your own legal, regulatory and professional review before any introduction or use. No efficacy, safety or clinical outcome is guaranteed.

Request information or a consultation

Please include your organization, country or region, product of interest and intended use.